MEDICLIN AG (DE:MED)

XETRA:MED

MED

MEDICLIN

RESEARCH TOOLSreports

Want to see DE:MED full AI Analyst Report?

MEDICLIN (MED) Price & Analysis

1 Followers

MED Stock Chart & Stats

€3.60

-€0.06(-2.44%)

At close: Jan 08 4:00 PM EST

€3.60

-€0.06(-2.44%)

Day’s Range― - ―

52-Week Range€2.86 - €4.06

Previous CloseN/A

Volume500.00

Average Volume (3M)5.25K

Market Cap

€161.50M

Enterprise Value€480.15M

Total Cash (Recent Filing)€72.18M

Total Debt (Recent Filing)€390.83M

Price to Earnings (P/E)6.9

Beta0.25

Next Earnings

May 04, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.12%

Share Statistics

EPS (TTM)<0.01

Shares Outstanding47,500,000

10 Day Avg. Volume4,347

30 Day Avg. Volume5,253

Financial Highlights & Ratios

PEG Ratio1.79

Price to Book (P/B)0.71

Price to Sales (P/S)0.22

P/FCF Ratio3.42

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.78

Revenue Forecast (FY)€797.78M

Bulls Say, Bears Say

Bulls Say

Cash GenerationConsistent operating cash flow and a material FCF rebound in 2025 provide durable internal funding for capex, working capital and debt reduction. Reliable cash generation enhances resilience to demand shocks, supports reinvestment and reduces reliance on external financing over months to years.

Revenue And Profit RecoveryA sustained revenue uptrend coupled with a return to positive net income suggests recovering scale and service demand. Improving top-line and profitability support more predictable cash flows and the capacity to fund quality improvements or selective network expansion over the medium term.

Diversified Clinical OperationsA business model spanning inpatient, outpatient and rehabilitation creates multiple, recurring revenue streams tied to essential care. Capital intensity and regulatory requirements raise barriers to entry, supporting stable demand and a defensible market position for steady medium-term fundamentals.

Bears Say

High LeverageHistorically elevated leverage (>2x) reduces financial flexibility, increasing interest costs and constraining the ability to absorb downturns or fund growth without new financing. Partial de-risking in 2025 helps, but the balance sheet remains a medium-term constraint on strategic optionality.

Margin VolatilitySharp swings in profitability and a significant drop in gross profit in 2025 indicate weak margin durability. Persistent margin volatility undermines forecasting, can pressure investment plans and makes sustained cash generation less predictable across business cycles.

Free Cash Flow VariabilityMaterial year-to-year FCF variability points to operational and timing risks (working capital, reimbursement cycles). Even with a strong 2025, inconsistent FCF reduces reliability for deleveraging, dividends or capex, requiring larger liquidity buffers or external funding if headwinds recur.

MED FAQ

What was MEDICLIN AG’s price range in the past 12 months?

MEDICLIN AG lowest stock price was €2.86 and its highest was €4.06 in the past 12 months.

What is MEDICLIN AG’s market cap?

MEDICLIN AG’s market cap is €161.50M.

When is MEDICLIN AG’s upcoming earnings report date?

MEDICLIN AG’s upcoming earnings report date is May 04, 2026 which is in 7 days.

How were MEDICLIN AG’s earnings last quarter?

MEDICLIN AG released its earnings results on Mar 27, 2026. The company reported €0.008 earnings per share for the quarter, beating the consensus estimate of N/A by €0.008.

Is MEDICLIN AG overvalued?

According to Wall Street analysts MEDICLIN AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MEDICLIN AG pay dividends?

MEDICLIN AG pays a Annually dividend of €0.04 which represents an annual dividend yield of 1.12%. See more information on MEDICLIN AG dividends here

What is MEDICLIN AG’s EPS estimate?

MEDICLIN AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MEDICLIN AG have?

MEDICLIN AG has 47,500,000 shares outstanding.

What happened to MEDICLIN AG’s price movement after its last earnings report?

MEDICLIN AG reported an EPS of €0.008 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.233%.

Which hedge fund is a major shareholder of MEDICLIN AG?

Currently, no hedge funds are holding shares in DE:MED

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

MEDICLIN Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

10.71%

Trailing 12-Months

Asset Growth

-8.82%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

MEDICLIN AG

MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopaedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, surgery, nursing care, and others. The company also provides services in the areas of ENT and acute outpatient services. As of December 31, 2021, it owned 34 clinics, 7 nursing care facilities, and 11 medical care centres with a total capacity of 7,831 beds and 482 nursing places in 11 German federal states. The company is headquartered in Offenburg, Germany.